Socrus Bio Sciences Peer Comparison

BSE: 524719

₹0.48

₹0.00 (0.00%)

As on 03-Aug-2015IST

Market cap

₹2 Cr

Revenue (TTM)

₹1 Cr

P/E Ratio

--

P/B Ratio

1.1

Div. Yield

0 %

Edit

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Market cap (₹ Cr)	2	2,746	269	241	68
Revenue (₹ Cr)	1	2,901	138	85	45
Net Profit (₹ Cr)	-0.12	16.16	-9.39	12.82	-16.64
Net Margin (%)	--	0.55	-6.66	6.38	-36.43
RoE (%)	--	0.29	-9.20	20.84	--
Price to Earnings	--	169.93	--	18.78	--
Price-To-Book	1.10	0.41	2.85	7.51	--

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Operating Revenue	19.89	0.00	127.12	831.97	172.80
Total Income	19.89	0.91	130.47	838.62	173.88
Total Expenditure	54.93	0.00	105.56	670.57	163.55
EBITDA	-35.04	0.00	21.56	161.41	9.25
Depreciation	4.32	--	11.70	46.38	1.26
EBIT	-39.36	0.00	9.86	115.03	7.99
Interest	0.00	0.88	20.78	14.38	2.20
Other Income	0.04	0.91	3.35	6.64	1.08
Exceptional Items	--	--	7.97	--	1.10
Profit before Tax	-39.36	0.03	0.41	107.29	6.87
Provision for Tax	1.33	0.01	--	18.19	1.86
Profit after Tax	-39.36	0.02	0.41	89.11	5.02

Liabilities (₹ Cr)

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Shareholder's Funds	1.27	0.07	66.95	420.42	41.95
Minority Interest	--	--	2.81	45.69	--
Non-Current Liabilities	-0.63	9.56	71.93	112.66	-1.88
Current Liabilities	0.97	0.09	147.21	257.92	44.98
Total Liabilities	2.24	9.71	288.90	836.68	89.80

Assets (₹ Cr)

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Non-Current Assets	0.36	0.00	162.24	376.46	8.21
Current Assets	1.26	9.71	126.66	460.22	76.84
Total Assets	2.24	9.71	288.90	836.68	89.80
Total Debt*	0.00	9.56	149.26	196.23	0.00
Net Current Assets	0.29	9.63	-20.55	202.30	31.86
Contingent Liabilities	1.33	--	56.30	8.19	6.57

Cashflow (₹ Cr)

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Cash From Operating Activities	-3.30	-1.71	10.94	116.63	31.35
Cash Flow from Investing Activities	3.26	0.92	4.54	-69.93	0.37
Cash from Financing Activities	--	0.79	-12.52	-30.80	-0.31
Net Cash Inflow / Outflow	-0.04	-0.01	2.97	15.90	31.42

Ratios

Profitability Ratios

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
ROCE (%)	-187.83	9.84	10.68	21.14	23.51
ROE (%)	-187.84	36.64	0.73	23.38	14.27
ROA (%)	-188.87	0.23	0.14	11.30	6.31
EBIT Margin (%)	-176.20	--	19.59	20.20	5.98
Net Margin (%)	-197.92	2.32	0.31	10.63	2.88
Cash Profit Margin (%)	-176.21	--	9.05	16.28	3.63

Growth Ratios

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Revenue Growth (%)	-34.06	--	-25.19	18.23	272.88
EBIT Growth (%)	-638.57	320.64	30.14	4.87	58.81
Net Profit Growth (%)	-868.59	-4.72	105.43	-5.37	-60.08
EPS Growth (%)	-868.59	-4.72	89.74	-7.14	-60.08
Book Value Growth (%)	-96.86	44.86	-1.25	22.96	48.00

Valuation Ratios

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Price / Earnings	0.00	0.00	0.00	3.28	10.45
Price / Book Value	2.96	0.00	0.35	0.62	1.25
Dividend Yield (%)	0.00	--	0.00	4.60	0.00
EV/EBITDA	-0.11	10.56	6.62	2.27	1.07
Market Cap (₹ Cr)	3.78	--	19.42	261.00	52.42

Solvency Ratios

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Debt to Equity	0.00	140.15	2.62	0.47	0.00
Short term debt to equity ratio	--	--	0.88	0.21	0.24
Current Ratio	1.30	110.08	0.86	1.78	1.71
Quick Ratio	0.36	110.08	0.74	1.72	0.99
Interest Coverage	0.00	1.03	1.02	8.46	4.13

Operating Efficiency Ratios

	Socrus Bio Sciences	Dishman Carbogen	Lyka Labs	Take Solutions	Bharat Immuno
Debtors to sales (%)	22.62	--	57.74	26.99	0.62
Asset Turnover	0.95	0.00	0.47	1.05	2.18
Receivable days	0.00	--	183.49	84.10	29.17
Inventory Days	63.94	--	46.62	7.37	54.73
Payable days	5.60	--	222.63	65.33	62.78
Cash Conversion Cycle	58.34	--	7.48	26.14	21.12

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly